Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan

Szu Min Hsieh, Ming Che Liu, Yen Hsu Chen, Wen Sen Lee, Shinn Jang Hwang, Shu Hsing Cheng, Wen Chien Ko, Kao Pin Hwang, Ning Chi Wang, Yu Lin Lee, Yi Ling Lin, Shin Ru Shih, Chung Guei Huang, Chun Che Liao, Jian Jong Liang, Chih Shin Chang, Charles Chen, Chia En Lien, I. Chen Tai, Tzou Yien Lin

研究成果: 雜誌貢獻文章同行評審

12 引文 斯高帕斯(Scopus)

指紋

深入研究「Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan」主題。共同形成了獨特的指紋。

Medicine & Life Sciences